“…10-Deacetylbaccatin III was obtained from Indena, SpA, Italy. 10-Cyclopropanecarbonyl-10-deacetyl-2-debenzoyl-2-(3-fluorobenzonyl)-7-triethylsilylbaccatin III ( 5 ) [35], (3 R ,4 S )-1- tert -butoxycarbonyl-3-triisoproylsilyloxy-4-(2-methyl-1-propenyl)-2-azetidinone ( 6 ) [39], 5-fluoro-3 H –benzo[ b ]thiophene ( 8 ) [40], triisopropylsilyl 4-(pyridine-2-yldisulfanyl)pentanoate ( 11 ) [5], biotinylhydrazine ( 16 ) [42], 10-deacetyl-2-debenzoyl-7,10,13-tris(triethylsilyl)baccatin III ( 17 ) [35], (3 R ,4 R )-1-( tert -butoxycarbonyl)-3-triisopropylsiloxy-4-trifluoromethylazetidin-2-one ( 22 ) [43], 2-(5-oxo-triisopropylsiloxypentan-2-yl)disulfanylphenylacetic acid ( 24 ) [5], and biotinyl-NH(PEG) 3 (CH 2 ) 2 -NH 2 ( 27 ) [45] were prepared according to literature methods. Human peripheral blood plasma (HemaCare), 0.9% sodium chloride injection saline with 10% dextrose (Baxter Healthcare Corp.), RPMI cell culture medium, and phosphate-buffered saline (PBS) (Gibco) were used as received for formulation and NMR-based assays.…”